-
-
Record Licensing Deal Values Transform Biotech M&A Strategies Across Global Markets
-
Biosimilar Competition Reshapes Biotech Investment Landscape as Patents Expire
Breaking Down the FDA Approval Catalyst That Could Transform Your Biotech Portfolio
Global Capital Follows Every Market Authorization Granted to Revolutionary Biotech Companies
Critical Phase 3 Trial Results Signal Major Shifts for Biotech Investment Strategies
In The News
- Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds May 16, 2026 By News Team
- Experimentally validated AI model predicts virulence of tomato yellow leaf curl virus May 16, 2026 By News Team
- Employment and funding growth fell in 2025: California Life Sciences report May 16, 2026 By News Team
- Makary’s reported FDA removal could be ‘broad positive’ for biopharma May 12, 2026 By News Team
- Can AI-embodied surgical robots revolutionize surgery? May 07, 2026 By News Team
Biotechnology Daily
more-
Breakthrough Therapy Designation Transforms Drug Development Into Lucrative Investment Opportunity
The pharmaceutical industry has witnessed a remarkable transformation in how promising treatments reach patients, fundamentally…
Breaking Down the FDA Approval Catalyst That Could Transform Your Biotech Portfolio
Breaking Down the IND Filing Revolution Transforming Modern Drug Development
Discovery could reshape RNA editing with DNA-guided CRISPR
Experimentally validated AI model predicts virulence of tomato yellow leaf curl virus
Market Watch
more-
Biosimilar Competition Reshapes Biotech Investment Landscape as Patents Expire
The biotech sector is experiencing unprecedented volatility as biosimilar competition intensifies across multiple therapeutic areas.…
Explosive Biotech Short Squeeze Activity Triggers Major Stock Movements Across the Sector
Analysts Reveal Why Orphan Drug Status Creates Hidden Investment Goldmines
Behind the Biotech Gold Rush: Orphan Drug Status Transforms Market Dynamics
Orphan Drug Status Designation Triggers Major Biotech Stock Movements
Bio Business News
moreRecord Licensing Deal Values Transform Biotech M&A Strategies Across Global Markets
The biotechnology sector is witnessing a fundamental shift in merger…
Record Licensing Deal Value Transforms Big Pharma’s Growth Strategy
The pharmaceutical industry is witnessing a fundamental shift in how…
Interim CDER head Høeg is out days after Makary: report
Just a few days after FDA Commissioner Makary resigned, ally…
World News
moreGlobal Capital Follows Every Market Authorization Granted to Revolutionary Biotech Companies
The moment a market authorization granted announcement hits the wires,…
How lungs balance defense and damage by tuning responses to deeper threats
Barrier organs that form boundaries between the body and the…
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
The antiviral drug ensitrelvir prevents infection in household contacts of…
Breakthrough Therapy Designation Transforms Drug Development Into Lucrative Investment Opportunity
Record Licensing Deal Values Transform Biotech M&A Strategies Across Global Markets
Biosimilar Competition Reshapes Biotech Investment Landscape as Patents Expire
Breaking Down the FDA Approval Catalyst That Could Transform Your Biotech Portfolio
Global Capital Follows Every Market Authorization Granted to Revolutionary Biotech Companies
Critical Phase 3 Trial Results Signal Major Shifts for Biotech Investment Strategies
Explosive Biotech Short Squeeze Activity Triggers Major Stock Movements Across the Sector
Record Licensing Deal Value Transforms Big Pharma’s Growth Strategy
Breaking Down the IND Filing Revolution Transforming Modern Drug Development
How lungs balance defense and damage by tuning responses to deeper threats